Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Deborah D. Giera"'
Autor:
Eric S. Nisenbaum, Darryle D. Schoepp, Gerard J. Marek, David L. McKinzie, James A. Monn, Ann E. Kingston, M. Herin, John T. Catlow, Bryan G. Johnson, Jennifer L. Burkey, Deborah D. Giera, Linda M. Rorick-Kehn, Rebecca A. Wright, David O. Calligaro
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 321:308-317
Group II metabotropic glutamate (mGlu) receptor agonists, including (1 S ,2 S ,5 R ,6 S )-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate monohydrate (LY354740) and (–)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), have demonstrated
Autor:
Sherri L. Andis, Steven S. Henry, Darryle D. Schoepp, Deborah D. Giera, Rebecca A. Wright, and Ann E. Kingston, Marc Herin, Gregory A. Stephenson, Bryan G. Johnson, Steven Marc Massey, John T. Catlow, Mark G. Bures, Matthew John Valli, James A. Monn
Publikováno v:
Journal of Medicinal Chemistry. 50:233-240
(-)-4-Amino-2-thiabicyclo-[3.1.0]hexane-4,6-dicarboxylate (LY389795, (-)-3) is a highly potent and selective agonist of metabotropic glutamate receptors 2 (mGlu2) and 3 (mGlu3). As part of our ongoing research program, we have prepared S-oxidized var
Autor:
and Lea M. Johnson, Bryan D. Anderson, Paul Lee, Miriam del Prado, C. Richard NevillJr., Sehila Pleite, Yong Wang, † Jaime Blanco-Urgoiti, Luisa M. Martín Cabrejas, Jeremy Schulenburg York, Robert M. Campbell, Deborah D. Giera, Michal Vieth, Jeffrey A. Wolos, Denis J. McCann, Chuan Shih, Li C. Li, Beatriz López de Uralde, Nicholas A. Magnus, Concepción Sánchez, Rosanne Bonjouklian, Richard M. Schultz, María José Lorite, Alfonso De Dios
Publikováno v:
Journal of Medicinal Chemistry. 48:2270-2273
We report the design and discovery of a 2-aminobenzimidazole-based series of potent and highly selective p38alphainhibitors. The lead compound 1 had low-nanomolar activity in both ATP competitive enzyme binding and inhibition of TNFalpha release in m
Publikováno v:
Toxicological Sciences. 16:348-355
Autor:
Linda M, Rorick-Kehn, Bryan G, Johnson, Jennifer L, Burkey, Rebecca A, Wright, David O, Calligaro, Gerard J, Marek, Eric S, Nisenbaum, John T, Catlow, Ann E, Kingston, Deborah D, Giera, Marc F, Herin, James A, Monn, David L, McKinzie, Darryle D, Schoepp
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 321(1)
Group II metabotropic glutamate (mGlu) receptor agonists, including (1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268), have demonstrated efficacy
Autor:
Jose Eduardo Lopez, James H Wikel, Mary Margaret Mader, Beth A Hollister, Luisa M Martin Cabrejas, Beverly Teicher, James A Aikins, Enrique Alvarez, Philip A Hipskind, Deborah D Giera, Michael E Richett, Rafael Ferritto, Karen L Lobb, Denis J. McCann, Gregory L Durst, Wesley T White, Alfonso De Dios, Cora Sue Grossman, John E. Reilly, Eileen L Considine, Victoriano Molero, Shih Chuan, Tiechao Li, Ho-Shen Lin, Beatriz Lopez, Zhongping Huang, Philip W Iversen, Yiu-Yin Cheung, Kevin L Law
Publikováno v:
Journal of medicinal chemistry. 47(22)
Two closely related diaryl acylsulfonamides were recently reported as potent antitumor agents against a broad spectrum of human tumor xenografts (colon, lung, breast, ovary, and prostate) in nude mice. Especially intriguing was their activity against
Autor:
Gerald F. Smith, Matthew J. Fisher, John E. Toth, Nickolay Y. Chirgadze, Deborah D. Giera, Dianna L. Bailey, John A. Buben, Amy Clemens-Smith, Michael L. Denney, Michael Enrico Richett, Richard Waltz Harper, Jolie Anne Bastian, Alan David Palkowitz, Minsheng Zhang, Valentine J. Klimkowski, Todd J. Kohn, Jefferson Ray Mccowan, Kumiko Takeuchi, Ho-Shen Lin, Daniel Jon Sall, Donetta S. Gifford-Moore, Lea M. Johnson, David W. Snyder
Publikováno v:
Journal of medicinal chemistry. 43(4)
A systematic investigation of the structure-activity relationships of the C-3 side chain of the screening hit 1a led to the identification of the potent thrombin inhibitors 23c, 28c, and 31c. Their activities (1240, 903, and 1271 x 10(6) L/mol, respe
Autor:
Nickolay Y. Chirgadze, Kenneth Lee Hauser, Ho-Shen Lin, Kenneth Jeff Thrasher, Stephen L. Briggs, Gerald F. Smith, Michael L. Denney, Sau-Chi B. Yan, Daniel Jon Sall, John A. Buben, K. Takeuchi, Donetta S. Gifford-Moore, Valentine J. Klimkowski, Jefferson Ray Mccowan, Barbara G. Utterback, David K. Clawson, Jolie Anne Bastian, Alan David Palkowitz, Minsheng Zhang, Richard Waltz Harper, Deborah D. Giera, Todd J. Kohn, Jennifer M. Tinsley
Publikováno v:
Journal of medicinal chemistry. 40(22)
Publikováno v:
Fundamental and applied toxicology : official journal of the Society of Toxicology. 16(2)
Assessment of hepatic ω-oxidation of fatty acids by cytochrome P450IV enzymes in toxicology studies can be a means of evaluating test compound effects on peroxisomal proliferation. Routine assay of ω-oxidation, however, requires a simpler method of
Publikováno v:
Proceedings, annual meeting, Electron Microscopy Society of America. 50:612-613
In vitro exposure to LY237216 (9-Deoxo-11-deoxy-9,11-{imino[2-(2-methoxyethoxy)ethylidene]-oxy}-(9S)-erythromycin), a macrolide antibiotic, was found to induce cytoplasmic vacuolation in L6 skeletal muscle myoblast cultures (White, S.L., unpubl). The